Drugs / Debio 1453P
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07035769 | Jun 2025 → Oct 2026 expected | — | Debiopharm International SA | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Debio 1453P | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07035769 ↗ |
| Route | Oral | “Single and Multiple Oral Doses of Debio 1453P” NCT07035769 ↗ |